Galantamine Hbr cures mild to moderate symptom alzheimers or vascular dementias symptoms. Galantamine is produced from natural resources and a patented total synthesis process. It is an anti-alzheimer’s agent that comes under the class cholinesterase inhibitor. It is also an allosteric ligand at nicotinic acetylcholine receptors. It works by reducing the action of AChE and therefore tends to increase the concentration of acetylcholine in the brain. This process helps to cure symptoms of mild to moderate dementia in patients with Alzheimer disease.

Dementias symptoms include memory losses, impaired abstraction and planning, language and comprehension disturbances, poor judgment, impaired orientation ability, decreased attention and increased restlessness and behavioral changes and psychosis. Dementia is caused by gradual death of cells in the brain. It is sometimes accompanied by emotional disturbance and personality changes. The loss of mental ability interferes with normal day to day activities that last for more than six months. However, it is not present since birth and is not associated with a loss or alteration of consciousness.

Alzheimer’s disease or AD is the most common cause of dementia, followed by vascular dementias. AD is incurable and often proves fatal. However, there are several drugs that may slow its progression. Symptom alzheimers accounts for one-half to three-fourths of all cases for dementia. Vascular dementias are estimated to cause from 5% to 30% of all dementias. It usually progresses with stroke, infection and heart disease that can lead to death. It occurs from decrease in blood flow to the brain, most commonly due to a series of small strokes called multi-infarct dementia. Because of the usually sudden nature of its cause, the symptoms of vascular dementia tend to begin more abruptly than those of Alzheimer’s dementia. Its symptoms may progress stepwise with the occurrence of new strokes.

]]>

Care for a person with dementia can be difficult and complex. In progressive dementias such as AD, the person may ultimately become completely dependent. Family members or others caring for a person with dementia often are subject to extreme stress. Since dementia usually progresses slowly, its diagnosing can be difficult in early stages. But, early diagnosis is important as the treatments can cure the early stages.

Diagnosis includes thorough physical examination and complete medical history. A variety of medical tests may require to determining the cause of dementia. The FDA has approved five prescription drugs for the treatment of AD symptoms. Four of these are used to treat mild to moderate AD. They are galantamine (Razadyne formerly known as Reminyl), rivastigmine (Exelon), donepezil (Aricept), and tacrine (Cognex).

Galantamines are available in the market under brand names Razadyne and Reminyl in the forms of tablets, capsules and oral solution. Galantamine hydrobromide under the name Reminyl was approved on February 2001 for use in mild to moderate dementia of the Alzheimer’s type. And under the name Razadyne, it was approved on August 28, 2008.

Galantamine has been used for decades in Eastern Europe and the USSR for various indications such as treatment of myasthenia, myopathy, and sensory and motor